This patent teaches how to induce allogeneic tolerance to transplanted grafts through making the recipient a chimera in terms of blood composition. In other words, donor hematopoietic stem cells are administered in order to make the recipient have both donor blood cells circulating, as well as some left over recipient cells.
This system has been shown effective in several animal models.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.